Walleye Trading
LAB icon

Walleye Trading’s Standard BioTools LAB Stock Holding History

Walleye Trading’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,125
Closed -$47K – 5418
2022
Q1 		$47K Sell
13,125
-6,042
-32% -$20.9K ﹤0.01% 4529
2021
Q4 		$75K Buy
19,167
+16,970
+772% +$79.4K ﹤0.01% 4513
2021
Q3 		$14K Buy
+2,197
New +$14.5K ﹤0.01% 4941
2020
Q2 		– Sell
-44,654
Closed -$113K – 4436
2020
Q1 		$113K Sell
44,654
-27,261
-38% -$89.6K ﹤0.01% 3029
2019
Q4 		$250K Buy
71,915
+65,211
+973% +$229K ﹤0.01% 2985
2019
Q3 		$31K Buy
+6,704
New +$52.8K ﹤0.01% 3688
2019
Q2 		– Sell
-28,988
Closed -$385K – 4276
2019
Q1 		$385K Buy
28,988
+14,100
+95% +$149K ﹤0.01% 2483
2018
Q4 		$128K Sell
14,888
-1,412
-9% -$11K ﹤0.01% 3746
2018
Q3 		$122K Buy
16,300
+1,700
+12% +$12.1K ﹤0.01% 4101
2018
Q2 		$87K Buy
+14,600
New +$83.2K ﹤0.01% 4107
2017
Q4 		– Sell
-29,962
Closed -$151K – 4499
2017
Q3 		$151K Sell
29,962
-3,500
-10% -$14.7K ﹤0.01% 3418
2017
Q2 		$135K Buy
33,462
+24,462
+272% +$116K ﹤0.01% 3380
2017
Q1 		$51K Buy
+9,000
New +$57K ﹤0.01% 3766
2016
Q4 		– Sell
-3,300
Closed -$26K – 4947
2016
Q3 		$26K Buy
3,300
+1,932
+141% +$17.7K ﹤0.01% 4084
2016
Q2 		$12K Buy
+1,368
New +$12.9K ﹤0.01% 4757
2015
Q1 		– Sell
-241
Closed -$9.53K – 4289
2014
Q4 		$8K Sell
241
-970
-80% -$27.5K ﹤0.01% 3958
2014
Q3 		$30K Buy
+1,211
New +$34K ﹤0.01% 3400

Other funds holding LAB

ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Trading's LAB Position: Q2 2022 in Review

Walleye Trading sold out of Standard BioTools (LAB) in Q2 2022, closing a stake of 13,125 shares — an estimated $47K sold.

Walleye Trading first reported a position in LAB in Q3 2014 and held it in 17 quarters. The position peaked at $385K in Q1 2019. 86 funds tracked by Wall St. Rank hold LAB as of Q2 2022.

  • Walleye Trading reported no remaining Standard BioTools position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 13,125 Standard BioTools shares in Q2 2022, an estimated $47K.
  • Walleye Trading first reported a position in Standard BioTools in Q3 2014 and held it in 17 quarters.
  • Walleye Trading's Standard BioTools position peaked at $385K in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.